InvestorsHub Logo
Followers 38
Posts 6888
Boards Moderated 1
Alias Born 09/06/2014

Re: faadifad post# 8967

Saturday, 07/28/2018 10:21:18 AM

Saturday, July 28, 2018 10:21:18 AM

Post# of 15618
IS it a viable product?

In the USA and other wealthy countries, I think yes. In Africa and Asia, I think not.

I don't think African and Asian governments want to know if women have cervical cancer because I don't think they want to pay for treatment. This is one of the cold hard unpleasant truths about the world.

So if this company is going to survive, they need FDA clearance in the USA. Looks like that is NEVER going to happen. The only way the Luviva Scan gets to the FDA goal line, IMO, is if some other company carries the ball.

GTHP can stagger down the Zombie Biotech road for a long time, doing an R/S whenever they need to put fresh lipstick on the pig. Toxic lenders will keep propping this thing up because they are making money here.

It's not the CEO's fault. That last FDA rejection came as a complete surprise, IMO. It was their 3rd attempt and they really believed they were going to get clearance, IMO, and that would have been an entirely different story.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GTHP News